Literature DB >> 28256435

The impact of motor symptoms on self-reported anxiety in Parkinson's disease.

Robert D Salazar1, Asher M Le1, Sandy Neargarder2, Alice Cronin-Golomb3.   

Abstract

OBJECTIVE: Anxiety is commonly endorsed in Parkinson's disease (PD) and significantly affects quality of life. The Beck Anxiety Inventory (BAI) is often used but contains items that overlap with common PD motor symptoms (e.g., "hands trembling"). Because of these overlapping items, we hypothesized that PD motor symptoms would significantly affect BAI scores.
METHODS: One hundred non-demented individuals with PD and 74 healthy control participants completed the BAI. PD motor symptoms were assessed by the Unified Parkinson's Disease Rating Scale (UPDRS). Factor analysis of the BAI assessed for a PD motor factor, and further analyses assessed how this factor affected BAI scores.
RESULTS: BAI scores were significantly higher for PD than NC. A five-item PD motor factor correlated with UPDRS observer-rated motor severity and mediated the PD-control difference on BAI total scores. An interaction occurred, whereby removal of the PD motor factor resulted in a significant reduction in BAI scores for PD relative to NC. The correlation between the BAI and UPDRS significantly declined when controlling for the PD motor factor.
CONCLUSIONS: The results indicate that commonly endorsed BAI items may reflect motor symptoms such as tremor instead of, or in addition to, genuine mood symptoms. These findings highlight the importance of considering motor symptoms in the assessment of anxiety in PD and point to the need for selecting anxiety measures that are less subject to contamination by the motor effects of movement disorders.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Motor symptoms; Parkinson's disease

Mesh:

Year:  2017        PMID: 28256435      PMCID: PMC5397358          DOI: 10.1016/j.parkreldis.2017.01.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  23 in total

1.  Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study.

Authors:  A F G Leentjens; K Dujardin; L Marsh; P Martinez-Martin; I H Richard; S E Starkstein
Journal:  Parkinsonism Relat Disord       Date:  2012-07-06       Impact factor: 4.891

Review 2.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

3.  SPSS and SAS procedures for estimating indirect effects in simple mediation models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods Instrum Comput       Date:  2004-11

Review 4.  Anxiety in Parkinson's disease: identification and management.

Authors:  Jack J Chen; Laura Marsh
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

5.  The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.

Authors:  Albert F G Leentjens; Kathy Dujardin; Gregory M Pontone; Sergio E Starkstein; Daniel Weintraub; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2014-05-23       Impact factor: 10.338

6.  Contribution of aging to the severity of different motor signs in Parkinson disease.

Authors:  Gilberto Levy; Elan D Louis; Lucien Cote; Mario Perez; Helen Mejia-Santana; Howard Andrews; Juliette Harris; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Karen Marder
Journal:  Arch Neurol       Date:  2005-03

7.  Anxiety in Parkinson's disease: Symptom dimensions and overlap with depression and autonomic failure.

Authors:  Sonja Rutten; Ires Ghielen; Chris Vriend; Adriaan W Hoogendoorn; Henk W Berendse; Albert F G Leentjens; Ysbrand D van der Werf; Jan H Smit; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2014-12-10       Impact factor: 4.891

Review 8.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

9.  Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis.

Authors:  P Martinez-Martin; J M Rojo-Abuin; K Dujardin; G M Pontone; D Weintraub; M J Forjaz; S Starkstein; A F G Leentjens
Journal:  Eur J Neurol       Date:  2013-04-14       Impact factor: 6.089

10.  Rasch analysis of anxiety scales in Parkinson's disease.

Authors:  Maria João Forjaz; Pablo Martinez-Martin; Kathy Dujardin; Laura Marsh; Irene H Richard; Sergio E Starkstein; Albert F G Leentjens
Journal:  J Psychosom Res       Date:  2013-03-19       Impact factor: 3.006

View more
  7 in total

Review 1.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

2.  Longitudinal Follow-Up of Mood in Cervical Dystonia and Influence on Age at Onset.

Authors:  Andrew Moriarty; Shameer Rafee; Ihedinachi Ndukwe; Sean O'Riordan; Michael Hutchinson
Journal:  Mov Disord Clin Pract       Date:  2022-04-28

3.  Stress Management Training (SMT) Improves Coping of Tremor-Boosting Psychosocial Stressors and Depression in Patients with Parkinson's Disease: A Controlled Prospective Study.

Authors:  C Buhmann; D Jungnickel; E Lehmann
Journal:  Parkinsons Dis       Date:  2018-10-28

4.  Gait Disorders Questionnaire-Promising Tool for Virtual Reality Designing in Patients With Parkinson's Disease.

Authors:  Zuzana Kosutzka; Alice Kusnirova; Michal Hajduk; Igor Straka; Michal Minar; Peter Valkovic
Journal:  Front Neurol       Date:  2019-09-24       Impact factor: 4.003

5.  Co-designing a remote rehabilitation tool for Parkinson's disease: exploratory values and challenges.

Authors:  Patricia Abril-Jiménez; Beatriz Merino-Barbancho; Cecilia Vera-Muñoz; María Teresa Arredondo Waldmeyer
Journal:  BMC Neurol       Date:  2021-12-16       Impact factor: 2.474

6.  Symptom dimensions of anxiety in Parkinson's disease: Replication study in a neuropsychiatric patient population.

Authors:  Sonja Rutten; Erwin E H van Wegen; Ires Ghielen; Bridget Schoon; Odile A van den Heuvel
Journal:  Clin Park Relat Disord       Date:  2021-11-10

7.  Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second lead.

Authors:  Stephanie Cernera; Robert S Eisinger; Joshua K Wong; Kwo Wei David Ho; Janine Lobo Lopes; Kevin To; Samuel Carbunaru; Adolfo Ramirez-Zamora; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  NPJ Parkinsons Dis       Date:  2020-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.